SEARCH RESULTS FOR: ("曲奇软fufu-白丝女儿服V2曲奇软fufu #白丝 #女儿服")(2235 results)

Export results
Filters
Sort By
50
Results Per Page
50
Results/Pg
Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

IMMUNOSUPPRESSANTS LEVEL 3 - B800IMMU3V2WBFPH0

IMMUNOSUPPRESSANTS LEVEL 3
UTAK LABORATORIES, INC.
IMMU 3 V2 WB F PH
In Commercial Distribution

  • B800IMMU3V2WBFPH5 ()
  • B800IMMU3V2WBFPH0 ()

  • Total Volume: 2 Milliliter
IMMU 3 V2 WB F PH

  • Multiple-type clinical chemistry analyte profile IVD, control

IMMUNOSUPPRESSANTS LEVEL 2 - B800IMMU2V2WBFPH0

IMMUNOSUPPRESSANTS LEVEL 2
UTAK LABORATORIES, INC.
IMMU 2 V2 WB F PH
In Commercial Distribution

  • B800IMMU2V2WBFPH5 ()
  • B800IMMU2V2WBFPH0 ()
IMMU 2 V2 WB F PH

  • Multiple-type clinical chemistry analyte profile IVD, control

IMMUNOSUPPRESSANTS LEVEL 1 - B800IMMU1V2WBFPH0

No Description
UTAK LABORATORIES, INC.
IMMU 1 V2 WB F PH
In Commercial Distribution

  • B800IMMU1V2WBFPH5 ()
  • B800IMMU1V2WBFPH0 ()

  • Total Volume: 2 Milliliter
IMMU 1 V2 WB F PH

  • Multiple-type clinical chemistry analyte profile IVD, control

GABAPENTIN PLUS - B800GABAVV2WBFMSP0

GABAPENTIN PLUS
UTAK LABORATORIES, INC.
GABA+ V V2 WB F MSP
In Commercial Distribution

  • B800GABAVV2WBFMSP5 ()
  • B800GABAVV2WBFMSP0 ()

  • Total Volume: 50 Milliliter
GABA+ V V2 WB F MSP

  • Multiple drugs of abuse IVD, control

GABAPENTIN LEVEL 2 - B800GABA2V2SMXUFPG0

GABAPENTIN LEVEL 2
UTAK LABORATORIES, INC.
GABA 2 V2 SMXU F PG
In Commercial Distribution

  • B800GABA2V2SMXUFPG5 ()
  • B800GABA2V2SMXUFPG0 ()

  • Total Volume: 2.5 Milliliter
GABA 2 V2 SMXU F PG

  • Multiple-type clinical chemistry analyte profile IVD, control

ETG PLUS LEVEL 3 - B800ETG3V2UFCCL0

ETG PLUS LEVEL 3
UTAK LABORATORIES, INC.
ETG+ 3 V2 U F CCL
In Commercial Distribution

  • B800ETG3V2UFCCL5 ()
  • B800ETG3V2UFCCL0 ()

  • Total Volume: 2 Milliliter
ETG+ 3 V2 U F CCL

  • Multiple-type clinical chemistry analyte profile IVD, control

ETG PLUS LEVEL 2 - B800ETG2V2UFCCL0

ETG PLUS LEVEL 2
UTAK LABORATORIES, INC.
ETG+ 2 V2 U F CCL
In Commercial Distribution

  • B800ETG2V2UFCCL5 ()
  • B800ETG2V2UFCCL0 ()

  • Total Volume: 2 Milliliter
ETG+ 2 V2 U F CCL

  • Multiple-type clinical chemistry analyte profile IVD, control

ETG PLUS LEVEL 1 - B800ETG1V2UFCCL0

ETG PLUS LEVEL 1
UTAK LABORATORIES, INC.
ETG+ 1 V2 U F CCL
In Commercial Distribution

  • B800ETG1V2UFCCL5 ()
  • B800ETG1V2UFCCL0 ()

  • Total Volume: 2 Milliliter
ETG+ 1 V2 U F CCL

  • Multiple-type clinical chemistry analyte profile IVD, control

DRUGS OF ABUSE CAL LEVEL 2 - B800DAULLEVEL2V2URMC0

DRUGS OF ABUSE CAL LEVEL 2
UTAK LABORATORIES, INC.
DAU+ L LEVEL 2 V2 URMC
In Commercial Distribution

  • B800DAULLEVEL2V2URMC5 ()
  • B800DAULLEVEL2V2URMC0 ()

  • Total Volume: 5 Milliliter
DAU+ L LEVEL 2 V2 URMC

  • Multiple drugs of abuse IVD, control

DRUGS OF ABUSE CAL LEVEL 1 - B800DAULLEVEL1V2URMC0

DRUGS OF ABUSE CAL LEVEL 1
UTAK LABORATORIES, INC.
DAU+ L LEVEL 1 V2 URMC
In Commercial Distribution

  • B800DAULLEVEL1V2URMC5 ()
  • B800DAULLEVEL1V2URMC0 ()

  • Total Volume: 5 Milliliter
DAU+ L LEVEL 1 V2 URMC

  • Multiple drugs of abuse IVD, control

DRUGS OF ABUSE LEVEL 3 - B800DAU3V2FUVMG0

DRUGS OF ABUSE LEVEL 3
UTAK LABORATORIES, INC.
DAU 3 V2 F U VMG
In Commercial Distribution

  • B800DAU3V2FUVMG0 ()
  • B800DAU3V2FUVMG05 ()
  • B800DAU3V2FUVMG5 ()

  • Total Volume: 10 Milliliter
DAU 3 V2 F U VMG

  • Multiple drugs of abuse IVD, control

DRUGS OF ABUSE LEVEL 2 - B800DAU2V2FUVMG0

DRUGS OF ABUSE LEVEL 2
UTAK LABORATORIES, INC.
DAU 2 V2 F U VMG
In Commercial Distribution

  • B800DAU2V2FUVMG5 ()
  • B800DAU2V2FUVMG0 ()

  • Total Volume: 10 Milliliter
DAU 2 V2 F U VMG

  • Multiple therapeutic drugs/drugs of abuse IVD, control

DRUGS OF ABUSE LEVEL 1 - B800DAU1V2FUVMG0

DRUGS OF ABUSE LEVEL 1
UTAK LABORATORIES, INC.
DAU 1 V2 F U VMG
In Commercial Distribution

  • B800DAU1V2FUVMG5 ()
  • B800DAU1V2FUVMG0 ()

  • Total Volume: 10 Milliliter
DAU 1 V2 F U VMG

  • Multiple drugs of abuse IVD, control

VORICONAZOLE PLUS 3 - B800VOR3V2SFUNC0

VORICONAZOLE PLUS 3
UTAK LABORATORIES, INC.
VOR+ 3 V2 S F UNC
In Commercial Distribution

  • B800VOR3V2SFUNC5 ()
  • B800VOR3V2SFUNC0 ()

  • Total Volume: 2 Milliliter
VOR+ 3 V2 S F UNC

  • Multiple-therapy therapeutic drug monitoring IVD, control

VORICONAZOLE PLUS 2 - B800VOR2V2SFUNC0

VORICONAZOLE PLUS 2
UTAK LABORATORIES, INC.
VOR+ 2 V2 S F UNC
In Commercial Distribution

  • B800VOR2V2SFUNC5 ()
  • B800VOR2V2SFUNC0 ()

  • Total Volume: 2 Milliliter
VOR+ 2 V2 S F UNC

  • Multiple-therapy therapeutic drug monitoring IVD, control

VORICONAZOLE PLUS 1 - B800VOR1V2SFUNC0

VORICONAZOLE PLUS 1
UTAK LABORATORIES, INC.
VOR+ 1 V2 S F UNC
In Commercial Distribution

  • B800VOR1V2SFUNC5 ()
  • B800VOR1V2SFUNC0 ()

  • Total Volume: 2 Milliliter
VOR+ 1 V2 S F UNC

  • Multiple-therapy therapeutic drug monitoring IVD, control

TESTOSTERONE 7.5 NG/DL - B800TESTO75V2SFLCMS0

TESTOSTERONE 7.5 NG/DL
UTAK LABORATORIES, INC.
TESTO 7.5 V2 S F LCMS
In Commercial Distribution

  • B800TESTO75V2SFLCMS5 ()
  • B800TESTO75V2SFLCMS0 ()

  • Total Volume: 1.1 Milliliter
TESTO 7.5 V2 S F LCMS

  • Multiple-type clinical chemistry analyte profile IVD, control

VOLATILES LEVEL 2 - B800VOL2V2SFRIH0

VOLATILES LEVEL 2
UTAK LABORATORIES, INC.
VOL 2 V2 S F RIH
In Commercial Distribution

  • B800VOL2V2SFRIH5 ()
  • B800VOL2V2SFRIH0 ()

  • Total Volume: 5 Milliliter
VOL 2 V2 S F RIH

  • Multiple drugs of abuse IVD, control

VOLATILES LEVEL 1 - B800VOL1V2SFRIH0

VOLATILES LEVEL 1
UTAK LABORATORIES, INC.
VOL 1 V2 S F RIH
In Commercial Distribution

  • B800VOL1V2SFRIH5 ()
  • B800VOL1V2SFRIH0 ()

  • Total Volume: 5 Milliliter
VOL 1 V2 S F RIH

  • Multiple drugs of abuse IVD, control

PETH LEVEL 3 - B800PETH3V2WBFMAYO0

PETH LEVEL 3
UTAK LABORATORIES, INC.
PETH 3 V2 WB F MAYO
In Commercial Distribution

  • B800PETH3V2WBFMAYO5 ()
  • B800PETH3V2WBFMAYO0 ()

  • Total Volume: 1 Milliliter
PETH 3 V2 WB F MAYO

  • Multiple-type clinical chemistry analyte profile IVD, control

OXAZEPAM GLUCURONIDE - B800OXAGLUCV2UFHCMC0

OXAZEPAM GLUCURONIDE
UTAK LABORATORIES, INC.
OXA GLUC V2 U F HCMC
In Commercial Distribution

  • B800OXAGLUCV2UFHCMC5 ()
  • B800OXAGLUCV2UFHCMC0 ()

  • Total Volume: 2 Milliliter
OXA GLUC V2 U F HCMC

  • Multiple drugs of abuse IVD, control

LEAD LEVEL 1 - B800LEAD1V2WBVWDL0

LEAD LEVEL 1
UTAK LABORATORIES, INC.
LEAD 1 V2 WB V WDL
In Commercial Distribution

  • B800LEAD1V2WBVWDL5 ()
  • B800LEAD1V2WBVWDL0 ()

  • Total Volume: 15 Milliliter
LEAD 1 V2 WB V WDL

  • Multiple-type clinical chemistry analyte profile IVD, control

LEAD LEVEL 1 - B800LEAD1V2WBFCH0

LEAD LEVEL 1
UTAK LABORATORIES, INC.
LEAD 1 V2 WB F CH
In Commercial Distribution

  • B800LEAD1V2WBFCH5 ()
  • B800LEAD1V2WBFCH0 ()

  • Total Volume: 0.5 Milliliter
LEAD 1 V2 WB F CH

  • Multiple-type clinical chemistry analyte profile IVD, control

ETHYLENE GLYCOL LEVEL 2 - B800ETHGLY2V2SFRIH0

ETHYLENE GLYCOL LEVEL 2
UTAK LABORATORIES, INC.
ETHGLY 2 V2 S F RIH
In Commercial Distribution

  • B800ETHGLY2V2SFRIH0 ()
  • B800ETHGLY2V2SFRIH5 ()

  • Total Volume: 5 Milliliter
ETHGLY 2 V2 S F RIH

  • Ethylene glycol IVD, control

DRUGS OF ABUSE QC 3 - B800DAUQC3V2FBILH0

DRUGS OF ABUSE QC 3
UTAK LABORATORIES, INC.
DAU QC 3 V2 F BILH
In Commercial Distribution

  • B800DAUQC3V2FBILH5 ()
  • B800DAUQC3V2FBILH0 ()

  • Total Volume: 2 Milliliter
DAU QC 3 V2 F BILH

  • Multiple-type clinical chemistry analyte profile IVD, control

DRUGS OF ABUSE QC 1 - B800DAUQC1V2FBILH0

DRUGS OF ABUSE QC 1
UTAK LABORATORIES, INC.
DAU QC 1 V2 F BILH
In Commercial Distribution

  • B800DAUQC1V2FBILH5 ()
  • B800DAUQC1V2FBILH0 ()

  • Total Volume: 2 Milliliter
DAU QC 1 V2 F BILH

  • Multiple-type clinical chemistry analyte profile IVD, control

DRUGS OF ABUSE POSITIVE - B800DAUPOSV2UFPHHC0

DRUGS OF ABUSE POSITIVE
UTAK LABORATORIES, INC.
DAU POS V2 U F PHHC
In Commercial Distribution

  • B800DAUPOSV2UFPHHC5 ()
  • B800DAUPOSV2UFPHHC0 ()

  • Total Volume: 3 Milliliter
DAU POS V2 U F PHHC

  • Multiple-type clinical chemistry analyte profile IVD, control

DRUGS OF ABUSE LOW - B800DALOWV2WBFBTL0

DRUGS OF ABUSE LOW
UTAK LABORATORIES, INC.
DA LOW V2 WB F BTL
In Commercial Distribution

  • B800DALOWV2WBFBTL5 ()
  • B800DALOWV2WBFBTL0 ()

  • Total Volume: 1 Milliliter
DA LOW V2 WB F BTL

  • Multiple drugs of abuse IVD, control

DRUGS OF ABUSE HIGH - B800DAHIGHV2WBFBTL0

DRUGS OF ABUSE HIGH
UTAK LABORATORIES, INC.
DA HIGH V2 WB F BTL
In Commercial Distribution

  • B800DAHIGHV2WBFBTL5 ()
  • B800DAHIGHV2WBFBTL0 ()

  • Total Volume: 1 Milliliter
DA HIGH V2 WB F BTL

  • Multiple drugs of abuse IVD, control

DRUGS OF ABUSE CUTOFF - B800DACUTV2SFPL0

DRUGS OF ABUSE CUTOFF
UTAK LABORATORIES, INC.
DA CUT V2 S F PL
In Commercial Distribution

  • B800DACUTV2SFPL5 ()
  • B800DACUTV2SFPL0 ()

  • Total Volume: 5 Milliliter
DA CUT V2 S F PL

  • Multiple-type clinical chemistry analyte profile IVD, control

DRUGS OF ABUSE LEVEL 2 - B800DA2V2FWBTDHS0

DRUGS OF ABUSE LEVEL 2
UTAK LABORATORIES, INC.
DA 2 V2 F WB TDHS
In Commercial Distribution

  • B800DA2V2FWBTDHS5 ()
  • B800DA2V2FWBTDHS0 ()

  • Total Volume: 5 Milliliter
DA 2 V2 F WB TDHS

  • Multiple drugs of abuse IVD, control

DRUGS OF ABUSE LEVEL 1 - B800DA1V2FWBTDHS0

DRUGS OF ABUSE LEVEL 1
UTAK LABORATORIES, INC.
DA 1 V2 F WB TDHS
In Commercial Distribution

  • B800DA1V2FWBTDHS5 ()
  • B800DA1V2FWBTDHS0 ()

  • Total Volume: 5 Milliliter
DA 1 V2 F WB TDHS

  • Multiple drugs of abuse IVD, control

COPPER PLUS LEVEL 2 - B800COP2V2SFUW0

COPPER PLUS LEVEL 2
UTAK LABORATORIES, INC.
COP+ 2 V2 S F UW
In Commercial Distribution

  • B800COP2V2SFUW5 ()
  • B800COP2V2SFUW0 ()

  • Total Volume: 5 Milliliter
COP+ 2 V2 S F UW

  • Multiple-type clinical chemistry analyte profile IVD, control

COPPER PLUS LEVEL 1 - B800COP1V2SFUW0

COPPER PLUS LEVEL 1
UTAK LABORATORIES, INC.
COP+ 1 V2 S F UW
In Commercial Distribution

  • B800COP1V2SFUW5 ()
  • B800COP1V2SFUW0 ()

  • Total Volume: 5 Milliliter
COP+ 1 V2 S F UW

  • Multiple-type clinical chemistry analyte profile IVD, control

CODEINE GLUCURONIDE PLUS LEVEL 2 - B800CODGLUC2V2UPM0

CODEINE GLUCURONIDE PLUS LEVEL 2
UTAK LABORATORIES, INC.
COD GLUC+ 2 V2 U PM
In Commercial Distribution

  • B800CODGLUC2V2UPM5 ()
  • B800CODGLUC2V2UPM0 ()

  • Total Volume: 3 Milliliter
COD GLUC+ 2 V2 U PM

  • Multiple-type clinical chemistry analyte profile IVD, control

CODEINE GLUCURONIDE PLUS LEVEL 1 - B800CODGLUC1V2UPM0

CODEINE GLUCURONIDE PLUS LEVEL 1
UTAK LABORATORIES, INC.
COD GLUC+ 1 V2 U PM
In Commercial Distribution

  • B800CODGLUC1V2UPM5 ()
  • B800CODGLUC1V2UPM0 ()

  • Total Volume: 3 Milliliter
COD GLUC+ 1 V2 U PM

  • Multiple-type clinical chemistry analyte profile IVD, control

CLOBAZAM PLUS LEVEL 3 - B800CLOB3V2SFMAYO0

CLOBAZAM PLUS LEVEL 3
UTAK LABORATORIES, INC.
CLOB+ 3 V2 S F MAYO
In Commercial Distribution

  • B800CLOB3V2SFMAYO5 ()
  • B800CLOB3V2SFMAYO0 ()

  • Total Volume: .5 Milliliter
CLOB+ 3 V2 S F MAYO

  • Multiple-type clinical chemistry analyte profile IVD, control

CLOBAZAM PLUS LEVEL 2 - B800CLOB2V2SFMAYO0

CLOBAZAM PLUS LEVEL 2
UTAK LABORATORIES, INC.
CLOB+ 2 V2 S F MAYO
In Commercial Distribution

  • B800CLOB2V2SFMAYO0 ()
  • B800CLOB2V2SFMAYO5 ()

  • Total Volume: .5 Milliliter
CLOB+ 2 V2 S F MAYO

  • Multiple-type clinical chemistry analyte profile IVD, control

CLOBAZAM PLUS LEVEL 1 - B800CLOB1V2SFMAYO0

CLOBAZAM PLUS LEVEL 1
UTAK LABORATORIES, INC.
CLOB+ 1 V2 S F MAYO
In Commercial Distribution

  • B800CLOB1V2SFMAYO5 ()
  • B800CLOB1V2SFMAYO0 ()

  • Total Volume: .5 Milliliter
CLOB+ 1 V2 S F MAYO

  • Multiple-type clinical chemistry analyte profile IVD, control

CCDKMQC2V2WBUK - B800CCDKMQC2V2WBUK0

CCDKMQC2V2WBUK
UTAK LABORATORIES, INC.
CCDKM QC 2 V2 WB UK
In Commercial Distribution

  • B800CCDKMQC2V2WBUK5 ()
  • B800CCDKMQC2V2WBUK0 ()

  • Total Volume: 3 Milliliter
CCDKM QC 2 V2 WB UK

  • Multiple-type clinical chemistry analyte profile IVD, control

ARSENIC PLUS LEVEL 3 - B800ARSEN3V2UFLC0

ARSENIC PLUS LEVEL 3
UTAK LABORATORIES, INC.
ARSEN+ 3 V2 U F LC
In Commercial Distribution

  • B800ARSEN3V2UFLC5 ()
  • B800ARSEN3V2UFLC0 ()

  • Total Volume: 2 Milliliter
ARSEN+ 3 V2 U F LC

  • Multiple-type clinical chemistry analyte profile IVD, control

ARSENIC PLUS LEVEL 2 - B800ARSEN2V2UFLC0

ARSENIC PLUS LEVEL 2
UTAK LABORATORIES, INC.
ARSEN+ 2 V2 U F LC
In Commercial Distribution

  • B800ARSEN2V2UFLC5 ()
  • B800ARSEN2V2UFLC0 ()

  • Total Volume: 2 Milliliter
ARSEN+ 2 V2 U F LC

  • Multiple-type clinical chemistry analyte profile IVD, control

ARSENIC PLUS LEVEL 1 - B800ARSEN1V2UFLC0

ARSENIC PLUS LEVEL 1
UTAK LABORATORIES, INC.
ARSEN+ 1 V2 U F LC
In Commercial Distribution

  • B800ARSEN1V2UFLC5 ()
  • B800ARSEN1V2UFLC0 ()

  • Total Volume: 2 Milliliter
ARSEN+ 1 V2 U F LC

  • Multiple-type clinical chemistry analyte profile IVD, control

AMITRIPTYLINE PLUS LEVEL 2 - B800AMIT2V2UFTRL0

AMITRIPTYLINE PLUS LEVEL 2
UTAK LABORATORIES, INC.
AMIT+ 2 V2 U F TRL
In Commercial Distribution

  • B800AMIT2V2UFTRL5 ()
  • B800AMIT2V2UFTRL0 ()

  • Total Volume: 1 Milliliter
AMIT+ 2 V2 U F TRL

  • Multiple-type clinical chemistry analyte profile IVD, control

ALPRAZOLAM PLUS LEVEL 3 - B800ALP3V2UFUK0

ALPRAZOLAM PLUS LEVEL 3
UTAK LABORATORIES, INC.
ALP+ 3 V2 U F UK
In Commercial Distribution

  • B800ALP3V2UFUK5 ()
  • B800ALP3V2UFUK0 ()

  • Total Volume: 2 Milliliter
ALP+ 3 V2 U F UK

  • Multiple-type clinical chemistry analyte profile IVD, control

ALPRAZOLAM PLUS LEVEL 3 - B800ALP3V2UFLENCO0

ALPRAZOLAM PLUS LEVEL 3
UTAK LABORATORIES, INC.
ALP+ 3 V2 U F LENCO
In Commercial Distribution

  • B800ALP3V2UFLENCO5 ()
  • B800ALP3V2UFLENCO0 ()

  • Total Volume: 2.5 Milliliter
ALP+ 3 V2 U F LENCO

  • Multiple-type clinical chemistry analyte profile IVD, control

ALPRAZOLAM PLUS LEVEL 2 - B800ALP2V2UFUK0

ALPRAZOLAM PLUS LEVEL 2
UTAK LABORATORIES, INC.
ALP+ 2 V2 U F UK
In Commercial Distribution

  • B800ALP2V2UFUK5 ()
  • B800ALP2V2UFUK0 ()

  • Total Volume: 2 Milliliter
ALP+ 2 V2 U F UK

  • Multiple-type clinical chemistry analyte profile IVD, control

ALPRAZOLAM PLUS LEVEL 2 - B800ALP2V2UFLENCO0

ALPRAZOLAM PLUS LEVEL 2
UTAK LABORATORIES, INC.
ALP+ 2 V2 U F LENCO
In Commercial Distribution

  • B800ALP2V2UFLENCO5 ()
  • B800ALP2V2UFLENCO0 ()

  • Total Volume: 2.5 Milliliter
ALP+ 2 V2 U F LENCO

  • Multiple-type clinical chemistry analyte profile IVD, control

ALPRAZOLAM PLUS LEVEL 1 - B800ALP1V2UFUK0

ALPRAZOLAM PLUS LEVEL 1
UTAK LABORATORIES, INC.
ALP+ 1 V2 U F UK
In Commercial Distribution

  • B800ALP1V2UFUK5 ()
  • B800ALP1V2UFUK0 ()

  • Total Volume: 2 Milliliter
ALP+ 1 V2 U F UK

  • Multiple-type clinical chemistry analyte profile IVD, control

ALPRAZOLAM PLUS LEVEL 1 - B800ALP1V2UFLENCO0

ALPRAZOLAM PLUS LEVEL 1
UTAK LABORATORIES, INC.
ALP+ 1 V2 U F LENCO
In Commercial Distribution

  • B800ALP1V2UFLENCO5 ()
  • B800ALP1V2UFLENCO0 ()

  • Total Volume: 2.5 Milliliter
ALP+ 1 V2 U F LENCO

  • Multiple-type clinical chemistry analyte profile IVD, control
< 1 ... 40 41 42 43 44 45 >